The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

Table 4

The CAIX expression according to clinicopathological features.

	Average	Standard deviation	Minimum	Lower quartile	Median	Upper quartile	Maximum	𝑃
FIGO stage
IA	3.26	2.61	0	0	3	6	9	NS
IB	4.53	1.74	2	3	6	6	6
II	4.07	2.16	0	2	5	6	6
IIIA	4.60	2.55	0	3	5	6	9
IIIC	4.71	2.52	0	2	6	6	9
IVB	3.67	2.34	0	2	4	6	6
Grading
1	2.86	1.86	0	2	3	4	6	NS
2	4.38	2.39	0	2	6	6	9
3	3.42	2.29	0	2	3	6	6
Bokhman subtype
1	4.19	2.35	0	2	4	6	9	NS
2	3.68	2.46	0	2	4	6	9
Lymph node metastases
0	3.96	2.34	0	2	4	6	9	NS
1	4.39	2.48	0	2	4	6	9
Distant metastases
0	4.09	2.38	0	2	4	6	9	NS
1	3.67	2.34	0	2	4	6	6
Myometrial invasion >50%
0	3.80	2.36	0	2	4	6	9	NS
1	4.49	2.36	0	3	4	6	9
Cervical infiltration
0	3.75	2.24	0	2	4	6	9	NS
1	4.50	2.50	0	2	6	6	9
Infiltration of adnexa
0	4.04	2.43	0	2	4	6	9	NS
1	4.27	2.00	0	3	4	6	6
Risk of recurrence
Low	4.05	2.50	0	2	4	6	9	NS
Intermediate and high	4.07	2.35	0	2	4	6	9